BCPC Balchem
- 181.080
- +0.560+0.31%
- 181.080
- 0.0000.00%
About Balchem Company
Balchem Corp. provides marketing of specialty performance ingredients and products. It operates through the following segments: Human Nutrition and Health, Animal Nutrition and Health and Specialty Products. The Human Nutrition and Health segment supplies ingredients in the food and beverage industry, providing customized solutions in powder, solid and liquid flavor delivery systems, spray dried emulsified powder systems, and cereal systems. The Animal Nutrition and Health segment consists of nutritional products derived from microencapsulation and chelation technologies in addition to basic choline chloride. The Specialty Products segment offers Ethylene oxide for the health care industry. The company was founded in January 1967 and is headquartered in Montvale, NJ.
Company Profile
Company Executives
- Name
- Position
- Salary
- Theodore L. Harris
- Chairman of the Board, President and Chief Executive Officer
- 5.89M
- William A. Backus
- Vice President and Chief Accounting Officer
- --
- C. Martin Bengtsson
- Executive Vice President and Chief Financial Officer
- 1.78M
- Dr. Michael Robert Sestrick, PhD
- Senior Vice President and Chief Technology Officer
- --
- Michael Bent Tignor
- Senior Vice President and Chief Human Resources Officer
- --
- Martin Luther Reid
- Senior Vice President and Chief Supply Chain Officer
- 1.15M
- Job van L. Gunsteren
- Senior Vice President and General Manager, Specialty Products
- --
- Frederic Boned
- Senior Vice President and General Manager, Human Nutrition and Health
- 1.14M
- Jonathan Harrison Griffin
- Senior Vice President, Corporate Development
- --
- Hatsuki Miyata
- Executive Vice President, General Counsel and Secretary
- 1.12M
- Monica Vicente
- Independent Director
- 21.67K
- Matthew D. Wineinger
- Lead Independent Director
- 216.46K
- Daniel E. Knutson
- Independent Director
- 226.26K
- Olivier Rigaud
- Independent Director
- 21.67K
- Kathleen B. Fish
- Independent Director
- 218.76K
- David B. Fischer
- Independent Director
- 211.26K
Analysis
Price Target
No Data
No Data